Seek truth from facts, competitive symbiosis
Notice of the First Extraordinary General Meeting of Shareholders in 2020
Category:
Release time:
2020-05-22
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Resolutions of the Eighth Meeting of the Sixth Board of Directors
And Notice of the First Extraordinary General Meeting of Shareholders in 2020
Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held the Eighth Meeting of the Sixth Board of Directors on May 22, 2020, at Zhengqing Group, Wealth Road No. 7, Huaihua High-tech Zone, Hunan. The notice of the meeting was delivered to all directors on May 16, 2020, by telephone, fax, and other means. The meeting was chaired by Mr. Wu Feichi, the Chairman. Five directors of the Company were supposed to attend the meeting, and five directors actually participated. The meeting adopted by voting resolution the "Proposal on Confirming the Company's Borrowing from Hunan Xiangjiang Liyuan Zhenghong Venture Capital Partnership (Limited Partnership) and Related Agreements" and the "Proposal on Confirming Huaihua Dadi Holdings Co., Ltd.'s Borrowing from the Company and Related Agreements" (as there were fewer than 3 non-related directors, these were directly submitted to the Shareholders' Meeting for deliberation), and submitted them to the Shareholders' Meeting for deliberation.
Notice of relevant matters for the Company's First Extraordinary General Meeting of Shareholders in 2020 is as follows:
1. Meeting Time: June 8, 2020, 9:30 AM
2. Meeting Venue: Zhengqing Group, Wealth Road No. 7, Huaihua High-tech Zone, Hunan
3. Meeting Convener: The Company's Board of Directors
4. Attendees:
(1) Company directors, supervisors, and senior management personnel;
(2) Shareholders registered as of June 1, 2020;
(3) Lawyers appointed by the Company and other personnel invited by the Company's Board of Directors.
I. Matters for Deliberation at the Meeting
The following proposals will be deliberated at this meeting:
1. "Proposal on Confirming the Company's Borrowing from Hunan Xiangjiang Liyuan Zhenghong Venture Capital Partnership (Limited Partnership) and Related Agreements";
2. "Proposal on Confirming Huaihua Dadi Holdings Co., Ltd.'s Borrowing from the Company and Related Agreements".
II. Meeting Registration Matters
1. Registration Time: June 6 and 7, 2020, 9:00 AM - 4:00 PM daily;
2. Registration Venue: Zhengqing Group, Wealth Road No. 7, Huaihua High-tech Zone, Hunan;
3. Corporate shareholders should register with the legal representative's ID card and business license; individual shareholders should register with their ID card and shareholding certificate (agents attending need to register with the agent's ID card and power of attorney; for a reference format of the power of attorney, please visit the company's website www.zq99.com to download).
III. Other Matters
1. The meeting will last half a day, and accommodation and meals are self-arranged;
2. Phone and Contact Persons: 0745—2508798 (Yang Xiuchun, Wen Xiaoping).
Board of Directors of Hunan Zhengqing Pharmaceutical Group Co., Ltd.
May 22, 2020
Power of Attorney
I hereby fully authorize Mr./Ms. ________ to represent me at the First Extraordinary General Meeting of Shareholders of Hunan Zhengqing Pharmaceutical Group Co., Ltd. held on June 8, 2020, and to exercise voting rights on my behalf.
The proxy shall exercise voting rights on the proposals deliberated at the meeting according to my instructions listed in the table below. For any ad-hoc proposals that may be included in the meeting's deliberation or other proposals for which I have not given specific instructions, the proxy (R has □ does not have) voting rights, and (R may □ may not) vote according to their own discretion, with all consequences of exercising the vote borne by me.
Serial Number
Matter for Deliberation
Voting Opinion
Agree
Disagree
Abstain
1
"Proposal on Confirming the Company's Borrowing from Hunan Xiangjiang Liyuan Zhenghong Venture Capital Partnership (Limited Partnership) and Related Transactions"
2
"Proposal on Confirming Huaihua Dadi Holdings Co., Ltd.'s Borrowing from the Company and Related Transactions"
Validity Period of Power of Attorney: From the date of signing this Power of Attorney until the conclusion of this Shareholders' Meeting.
Principal (Signature or Seal):
Legal Representative (Signature)
Proxy (Signature):
Proxy's ID Number:
Date of Authorization: Year Month Day
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地